HRJR7T.jpg

Harnessing The Power of
NK Cells to Defeat Cancer

 
 
iPSCimage%20(2)_edited.jpg

"Precision NK therapies have the potential to revolutionize cancer treatment with unsurpassed safety and efficacy. We are excited to bring NK Cell Engager antibodies and CAR-NK cell therapies to initial clinical trials starting in 2021, moving towards broad patient access to cancer-defeating cures."

- Dr. Daniel Teper, Cytovia Therapeutics CEO

 
 

Cytovia In The News

 
Microphones_edited.jpg

Watch a replay of the Cell Therapy panel at the 10th Annual LifeSci Partners Corporate Access Event, featuring our CEO Dr. Daniel Teper

January 7th, 2021

Watch a replay of Cytovia's recent fireside chat at the RBC Capital Markets Healthcare Conference, featuring CEO Dr. Daniel Teper and CSO Dr. Wei Li

December 16th, 2020

Subscribe Form

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube